JB CHEMICALS & PHARMACEUTICALS
|
JB CHEMICALS & PHARMACEUTICALS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 44.19 | 42.37 | 35.61 | 52.97 | 49.86 |
| CEPS(Rs) | 55.55 | 53.36 | 44.52 | 33.89 | 29.68 |
| DPS(Rs) | 22.00 | 15.50 | 12.25 | 17.75 | 16.50 |
| Book NAV/Share(Rs) | 259.05 | 209.75 | 179.35 | 304.83 | 268.04 |
| Tax Rate(%) | 25.50 | 25.67 | 26.46 | 26.16 | 23.54 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 27.60 | 27.30 | 24.76 | 21.28 | 21.81 |
| EBIT Margin(%) | 23.91 | 23.81 | 22.08 | 18.09 | 20.50 |
| Pre Tax Margin(%) | 23.77 | 23.50 | 20.85 | 16.98 | 20.29 |
| PAT Margin (%) | 17.71 | 17.47 | 15.33 | 12.54 | 15.51 |
| Cash Profit Margin (%) | 22.26 | 21.99 | 19.17 | 16.04 | 18.44 |
| Performance Ratios | |||||
| ROA(%) | 13.01 | 13.58 | 12.60 | 11.44 | 13.69 |
| ROE(%) | 19.11 | 21.81 | 21.49 | 18.51 | 19.89 |
| ROCE(%) | 25.19 | 26.73 | 25.23 | 22.79 | 25.48 |
| Asset Turnover(x) | 0.73 | 0.78 | 0.82 | 0.91 | 0.88 |
| Sales/Fixed Asset(x) | 1.34 | 1.30 | 1.32 | 1.46 | 1.63 |
| Working Capital/Sales(x) | 1.73 | 2.93 | 3.66 | 3.36 | 2.86 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.75 | 0.77 | 0.76 | 0.69 | 0.61 |
| Receivable days | 72.72 | 72.60 | 63.93 | 63.16 | 69.29 |
| Inventory Days | 55.23 | 49.85 | 47.24 | 46.91 | 55.55 |
| Payable days | 112.87 | 106.33 | 91.86 | 72.35 | 89.07 |
| Valuation Parameters | |||||
| PER(x) | 46.69 | 38.29 | 46.32 | 18.61 | 31.59 |
| PCE(x) | 37.14 | 30.40 | 37.05 | 29.08 | 26.54 |
| Price/Book(x) | 7.96 | 7.73 | 9.20 | 6.47 | 5.88 |
| Yield(%) | 1.07 | 0.96 | 0.74 | 0.90 | 1.05 |
| EV/Net Sales(x) | 7.95 | 6.42 | 7.42 | 4.99 | 5.01 |
| EV/Core EBITDA(x) | 28.25 | 23.49 | 27.68 | 22.28 | 20.84 |
| EV/EBIT(x) | 34.43 | 27.96 | 32.49 | 26.59 | 23.81 |
| EV/CE(x) | 7.93 | 7.29 | 7.88 | 5.19 | 3.96 |
| M Cap / Sales | 7.99 | 6.45 | 7.35 | 4.84 | 5.02 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 5.87 | 12.45 | 10.63 | 29.91 | 18.69 |
| Core EBITDA Growth(%) | 9.10 | 14.56 | 32.37 | 21.11 | -13.39 |
| EBIT Growth(%) | 6.54 | 12.98 | 34.59 | 15.93 | -15.58 |
| PAT Growth(%) | 7.56 | 19.35 | 34.79 | 6.21 | -13.93 |
| EPS Growth(%) | 4.29 | 18.98 | -32.77 | 6.22 | -13.98 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | 0.13 | 0.23 | 0.01 |
| Current Ratio(x) | 3.23 | 2.12 | 1.76 | 2.56 | 2.91 |
| Quick Ratio(x) | 2.58 | 1.66 | 1.37 | 1.87 | 2.01 |
| Interest Cover(x) | 172.03 | 76.66 | 17.95 | 16.40 | 99.60 |
| Total Debt/Mcap(x) | - | - | 0.01 | 0.04 | - |
Compare Financial Ratios of peers of JB CHEMICALS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JB CHEMICALS & PHARMACEUTICALS | ₹34,360.4 Cr | -2.8% | 2.9% | 27.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,926.0 Cr | -3% | -1.9% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,062.0 Cr | -3.3% | -0.7% | -1.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,806.0 Cr | -3.8% | 2.8% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,910.0 Cr | -3% | 3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,755.0 Cr | -4.3% | -2% | 2.5% | Stock Analytics | |
JB CHEMICALS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JB CHEMICALS & PHARMACEUTICALS | -2.8% |
2.9% |
27.7% |
| SENSEX | -2.2% |
-3.3% |
-8.8% |
You may also like the below Video Courses
